Search
News

A Survey for iPSC-derived ATMPs launched by HAPLO-iPS

HAPLO-iPS is conducting a short survey to better understand the landscape of projects using iPSC-derived Advanced Therapy Medicinal Products (ATMPs) for clinical applications in Europe.

Your input will help shape the agenda of an upcoming specially focused HAPLO-iPS workshop and ensure it addresses the needs of clinicians, researchers, and developers in this field. Participation will also allow you to register your interest in attending our workshop.

We kindly invite you to participate in the survey here: http://bit.ly/4opmHNj.

Share this post